Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine. On 13 September, both the US Food and Drug ...
Hosted on MSN7mon
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial rulingJudge Vivian Medinilla of the Delaware Superior Court said instead, the strength of ... The US Food and Drug Administration eventually asked manufacturers to pull Zantac off the market in 2020.
GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results